Home LiteratureArticle Details
PMID: 2675760 Published · ppublish English Journal Article Review

Methicillin-resistant staphylococci: detection methods and treatment of infections.

Antimicrobial agents and chemotherapy ·Vol. 33 ·No. 7 ·1989-07-00 ·Pages 995-9

Hackbarth CJ, Chambers HF

Abstract

暂无摘要

MeSH Terms
Humans Methicillin/pharmacology Microbial Sensitivity Tests Penicillin Resistance Staphylococcal Infections/drug therapy,microbiology Staphylococcus/drug effects
Chemicals
Methicillin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hackbarth C J
Medical Service, San Francisco General Hospital, California.
Chambers H F
References (88)
88 references, click to expand
  1. Early detection of oxacillin-resistant staphylococcal strains with hypertonic broth diluent for microdilution panels.
    J Clin Microbiol. 1984 Apr;19(4):473-6 PMID: 6562124
  2. Methicillin-resistant staphylococci.
    Clin Microbiol Rev. 1988 Apr;1(2):173-86 PMID: 3069195
  3. Methicillin-resistant staphylococci: genetics of the minority population.
    J Gen Microbiol. 1966 Feb;42(2):315-22 PMID: 5178721
  4. Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.
    Antimicrob Agents Chemother. 1989 Feb;33(2):181-4 PMID: 2719462
  5. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.
    J Infect Dis. 1979 Mar;139(3):273-9 PMID: 255552
  6. Selective inhibition of ribonucleic acid synthesis in Staphylococcus aureus by vancomycin.
    Nature. 1959 Dec 12;184(Suppl 24):1894-5 PMID: 14407860
  7. Fucidin-resistant staphylococci in current hospital practice.
    J Med Microbiol. 1973 May;6(2):235-44 PMID: 4488470
  8. CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI.
    J Bacteriol. 1964 Apr;87:887-99 PMID: 14137628
  9. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
    Antimicrob Agents Chemother. 1980 Feb;17(2):280-5 PMID: 7387148
  10. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
    Antimicrob Agents Chemother. 1986 Jan;29(1):26-9 PMID: 3460521
  11. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Antimicrob Agents Chemother. 1987 Apr;31(4):558-69 PMID: 3496845
  12. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Antimicrob Agents Chemother. 1982 Oct;22(4):662-71 PMID: 6295263
  13. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    J Infect Dis. 1984 Jun;149(6):894-903 PMID: 6564133
  14. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.
    Biochem J. 1971 Aug;123(5):789-803 PMID: 5124386
  15. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
    Antimicrob Agents Chemother. 1985 May;27(5):685-7 PMID: 3860185
  16. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control.
    Infect Control. 1981 Nov-Dec;2(6):453-9 PMID: 6915018
  17. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to sulfamethoxazole and trimethoprim.
    J Infect Dis. 1973 Nov;128:Suppl:543-4 p PMID: 4491133
  18. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
    Antimicrob Agents Chemother. 1985 Nov;28(5):634-8 PMID: 2936300
  19. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Ann Intern Med. 1982 Sep;97(3):376-8 PMID: 7114635
  20. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    J Infect Dis. 1980 Nov;142(5):725-31 PMID: 7462687
  21. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
    Antimicrob Agents Chemother. 1986 Apr;29(4):611-3 PMID: 3707110
  22. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
    Antimicrob Agents Chemother. 1987 Oct;31(10):1549-52 PMID: 3481245
  23. The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
    Annu Rev Microbiol. 1984;38:339-57 PMID: 6388496
  24. A prospective study of adverse reactions associated with vancomycin therapy.
    J Antimicrob Chemother. 1985 Aug;16(2):235-41 PMID: 3934126
  25. The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors.
    Biochem J. 1971 Oct;124(5):845-52 PMID: 4331859
  26. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Antimicrob Agents Chemother. 1986 Sep;30(3):382-4 PMID: 3640590
  27. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
    Antimicrob Agents Chemother. 1987 Feb;31(2):151-5 PMID: 3566245
  28. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.
    Antimicrob Agents Chemother. 1986 Jan;29(1):85-92 PMID: 3488015
  29. Evolutio of natural resistance to the newer penicillins.
    Br Med J. 1963 Feb 2;1(5326):308-11 PMID: 13984091
  30. Septicaemia due to colonization of Spitz-Holter valves by staphylococci. Five cases treated with methicillin.
    Br Med J. 1961 Mar 25;1(5229):860-3 PMID: 13689978
  31. Methicillin-resistant Staphylococcus aureus susceptibility testing with Abbott MS-2 system.
    Antimicrob Agents Chemother. 1982 Apr;21(4):676-7 PMID: 6919413
  32. Penicillinase production and intrinsic resistance to penicillins in methicillin-resistant cultures of Staphylococcus aureus.
    J Med Microbiol. 1969 Aug;2(3):261-78 PMID: 5405709
  33. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    J Infect Dis. 1987 Feb;155(2):187-91 PMID: 2949024
  34. Bacteremia due to methicillin-resistant Staphylococcus aureus.
    J Infect Dis. 1982 Apr;145(4):532-6 PMID: 6917874
  35. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Antimicrob Agents Chemother. 1987 Apr;31(4):539-43 PMID: 3606060
  36. Resistance of Staphylococcus aureus to semisynthetic penicillins and cephalothin.
    J Infect Dis. 1977 Jan;135(1):108-12 PMID: 583903
  37. Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    J Clin Microbiol. 1986 Nov;24(5):764-9 PMID: 3639887
  38. The newer penicillins.
    Clin Pharmacol Ther. 1961 Sep-Oct;2:572-80 PMID: 13724146
  39. Use of the Autobac system for detection of methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol. 1985 Sep;22(3):467-9 PMID: 3850094
  40. Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance.
    Antimicrob Agents Chemother. 1980 Apr;17(4):658-62 PMID: 6901593
  41. Reevaluation of the ability of the standardized disk diffusion test to detect methicillin-resistant strains of Staphylococcus aureus.
    J Clin Microbiol. 1984 Jun;19(6):813-7 PMID: 6565707
  42. Effect of inoculum size on in vitro susceptibility of methicillin-resistant Staphylococcus aureus to eighteen antimicrobial agents.
    Eur J Clin Microbiol. 1985 Feb;4(1):68-70 PMID: 3987682
  43. EFFECT OF VANCOMYCIN ON THE SYNTHESIS OF THE CELL WALL AND CYTOPLASMIC MEMBRANE OF STAPHYLOCOCCUS AUREUS.
    Can J Microbiol. 1965 Apr;11:390-3 PMID: 14323054
  44. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations.
    JAMA. 1976 Oct 4;236(14):1604-6 PMID: 989135
  45. Detection of methicillin-resistant Staphylococcus epidermidis.
    J Clin Microbiol. 1986 Sep;24(3):349-52 PMID: 3639087
  46. Variation in the abilities of automated, commercial, and reference methods to detect methicillin-resistant (heteroresistant) Staphylococcus aureus.
    J Clin Microbiol. 1984 Sep;20(3):494-9 PMID: 6490833
  47. Interaction between vancomycin and rifampin against Staphylococcus aureus.
    Antimicrob Agents Chemother. 1981 Jun;19(6):1089-91 PMID: 7271276
  48. Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems.
    J Clin Microbiol. 1983 Nov;18(5):1226-36 PMID: 6605976
  49. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.
    Am J Med. 1976 Sep;61(3):340-5 PMID: 1048860
  50. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.
    J Infect Dis. 1972 May;125(5):486-90 PMID: 5023643
  51. Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
    Antimicrob Agents Chemother. 1986 Dec;30(6):938-9 PMID: 3028254
  52. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
    J Clin Microbiol. 1986 May;23(5):832-9 PMID: 3011847
  53. Penicillinase-negative variants of methicillin-resistant Staphylococcus aureus.
    Nature. 1966 Mar 5;209(5027):994-6 PMID: 5180132
  54. Activity of novobiocin against methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 1985 Apr;15(4):435-40 PMID: 3847438
  55. In vitro susceptibilities of four species of coagulase-negative staphylococci.
    Antimicrob Agents Chemother. 1986 Oct;30(4):545-52 PMID: 3539009
  56. Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus.
    Appl Microbiol. 1972 Aug;24(2):240-7 PMID: 5071651
  57. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
    Antimicrob Agents Chemother. 1986 Jan;29(1):52-7 PMID: 2942100
  58. Emergence of vancomycin resistance in coagulase-negative staphylococci.
    N Engl J Med. 1987 Apr 9;316(15):927-31 PMID: 3821839
  59. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
    Antimicrob Agents Chemother. 1984 May;25(5):666-8 PMID: 6563877
  60. The effect of temperature on resistance of Staphylococcus aureus to methicillin and some other antibioics.
    Med J Aust. 1968 Mar 16;1(11):444-6 PMID: 5185252
  61. Suppression of intrinsic resistance to methicillin and other penicillins in Staphylococcus aureus.
    Antimicrob Agents Chemother. 1972 Nov;2(5):350-5 PMID: 4494489
  62. Liberation of surface-located penicillinase from Staphylococcus aureus.
    Biochem J. 1967 Mar;102(3):742-7 PMID: 16742488
  63. Methicillin-resistant Staphylococcus aureus bacteriuria.
    Am J Med Sci. 1981 Mar-Apr;281(2):101-9 PMID: 6908999
  64. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
    Antimicrob Agents Chemother. 1986 May;29(5):748-52 PMID: 3460523
  65. NATURALLY OCCURING METHICILLIN-RESISTANT STAPHYLOCOCCI.
    J Gen Microbiol. 1964 May;35:183-90 PMID: 14179667
  66. Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains.
    Antimicrob Agents Chemother. 1986 May;29(5):789-96 PMID: 3637066
  67. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Antimicrob Agents Chemother. 1982 Nov;22(5):903-5 PMID: 6924825
  68. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1986 Jun;29(6):1092-4 PMID: 3488022
  69. Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine.
    Biochem J. 1971 Aug;123(5):773-87 PMID: 5124385
  70. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.
    J Clin Microbiol. 1989 Feb;27(2):335-6 PMID: 2492540
  71. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Ann Intern Med. 1982 Sep;97(3):344-50 PMID: 7114631
  72. Reliability of the MS-2 system in detecting methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol. 1982 Feb;15(2):220-5 PMID: 6917854
  73. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
    JAMA. 1978 Oct 27;240(18):1963-5 PMID: 249793
  74. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 1987 Dec;31(12):1982-8 PMID: 3439805
  75. Methicillin-resistant staphylococci.
    J Clin Pathol. 1961 Jul;14:385-93 PMID: 13686776
  76. Autobac susceptibility testing of methicillin-resistant Staphylococcus aureus isolated in an Australian hospital.
    J Clin Microbiol. 1985 Nov;22(5):822-7 PMID: 3850902
  77. Effect of source of Mueller-Hinton agar on detection of oxacillin resistance in Staphylococcus aureus using a screening methodology.
    J Clin Microbiol. 1987 Apr;25(4):734-5 PMID: 3571481
  78. Reliability of the microdilution technic for detection of methicillin-resistant strains of staphylococcus aureus.
    Am J Clin Pathol. 1977 May;67(5):489-95 PMID: 324263
  79. Effect of salts on penicillinase release by Staphylococcus aureus.
    Microbios. 1974 Jun-Jul;10A SUPPL(41):55-63 PMID: 4457740
  80. Evaluation of the AutoMicrobic system Gram-Positive Susceptibility-MIC card for detection of oxacillin-resistant coagulase-negative staphylococci.
    J Clin Microbiol. 1986 Mar;23(3):629-30 PMID: 3633924
  81. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations.
    N Engl J Med. 1968 Aug 29;279(9):441-8 PMID: 4232865
  82. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.
    Chest. 1978 Mar;73(3):371-5 PMID: 630934
  83. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.
    J Clin Microbiol. 1983 Nov;18(5):1084-91 PMID: 6643661
  84. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1984 Jul;26(1):61-4 PMID: 6236747
  85. Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy.
    J Neurosurg. 1984 Feb;60(2):354-60 PMID: 6607326
  86. Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals.
    J Clin Microbiol. 1981 Apr;13(4):754-9 PMID: 6908898
  87. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.
    Antimicrob Agents Chemother. 1986 Oct;30(4):532-5 PMID: 3024560
  88. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.
    Antimicrob Agents Chemother. 1987 Feb;31(2):207-12 PMID: 2952062
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
DOI
10.1128/AAC.33.7.995
Published
1989-07-00
Pages
995-9
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC176051
Subset
IM
External Links
PubMed source DOI: 10.1128/AAC.33.7.995 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2